Inflammatory Arthritis Has Big Impact on Systemic Sclerosis Inflammatory Arthritis Has Big Impact on Systemic Sclerosis
In patients with SSc, the presence of inflammatory arthritis is significantly associated with diffuse disease, musculoskeletal manifestations, myositis, and sicca.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 15, 2024 Category: Dermatology Tags: Rheumatology Source Type: news

Anti-Acid Meds Lower Strength of Systemic Sclerosis Drug Anti-Acid Meds Lower Strength of Systemic Sclerosis Drug
Weakened bioavailability of mycophenolate mofetil could require adjustments in treatment.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 10, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Lupus May Overlap in Many Patients With Systemic Sclerosis Lupus May Overlap in Many Patients With Systemic Sclerosis
Patients with both systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) showed a distinct clinical phenotype from those with SSc alone, but mortality was similar.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

ILD Plus PH Equals Poor Outcomes in Systemic Sclerosis ILD Plus PH Equals Poor Outcomes in Systemic Sclerosis
Patients with systemic sclerosis who have both interstitial lung disease and pulmonary hypertension have worse survival than those without both conditions, based on data from more than 3000 individuals.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 30, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news

Autoantibodies Could Help Predict Cancer Risk in Scleroderma Autoantibodies Could Help Predict Cancer Risk in Scleroderma
The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were tied to reduced risk.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 3, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Vision Transformer for Capillaroscopy in Systemic Sclerosis Vision Transformer for Capillaroscopy in Systemic Sclerosis
Learn more about the promising potential of an AI-based tool for the assessment of capillaroscopy changes in patients with systemic sclerosis.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe
Nearly half of these patients had interstitial lung disease and had similar rates of scleroderma renal crisis, compared with the other disease subtypes.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 29, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Check SSc-ILD Patients on Ofev for Malnutrition, Study Suggests
(MedPage Today) -- During nintedanib (Ofev) treatment for interstitial lung disease associated with systemic sclerosis (SSc-ILD), clinicians prescribing the drug should be watchful for an unusual, indirect side effect, trial data suggested. Among... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - June 26, 2023 Category: Rheumatology Source Type: news

Liver Function Tests Can ID Occult Disorders in Systemic Sclerosis
WEDNESDAY, May 31, 2023 -- Liver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published online May 2 in Open Access Rheumatology:... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2023 Category: Pharmaceuticals Source Type: news

TREMFYA ® (guselkumab) Provides Sustained Improvements Across All Minimal Disease Activity Domains for Adults Living with Active Psoriatic Arthritis in Phase 3b Trial
SPRING HOUSE, PENNSYLVANIA, May 31, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment with TREMFYA® (guselkumab) provided sustainable improvements in all minimal disease activity (MDA)a domains through week 48 in adults living with active psoriatic arthritis (PsA) who previously had an inadequate response to one to two tumor necrosis factor inhibitors (TNFi-IR).[1] In a separate post-hoc analysis of the Phase 3 DISCOVER-1 and DISCOVER-2b clinical trial findings, TREMFYA was shown to be associated with prompt and su...
Source: Johnson and Johnson - May 31, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Hypochromic Red Cells and Survival in Systemic Sclerosis Hypochromic Red Cells and Survival in Systemic Sclerosis
What could the presence of hypochromic red cells tell us about survival in patients with systemic sclerosis?Arthritis Research & Therapy (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 1, 2023 Category: Transplant Surgery Tags: Rheumatology Journal Article Source Type: news

Blood Test Flags ILD in Systemic Sclerosis
(MedPage Today) -- Serum levels of three markers of pulmonary fibrosis pathology were significantly associated with the presence of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc) -- strongly enough to serve as a clinical... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 14, 2023 Category: Rheumatology Source Type: news

Black members pass motions on disability and cost of living crisis
There are an estimated 185,000 Black members in UNISON, the majority of whom work in health and local government services, and the union has declared 2023 as the Year of Black Workers. During the morning session, chaired by Kebba Manneh – the chair of the national Black members committee – conference passed motions on young Black members and mental health at work, and on Black members feeling undervalued and like they don’t belong. A key motion was unanimously passed on Black workers and non-apparent impairments. Introduced by Tansaim Hussain-Gul of the union’s national disabled members committee, the motion calle...
Source: UNISON Health care news - January 22, 2023 Category: UK Health Authors: Janey Starling Tags: Article News 2023 National Black Members Conference cost of living disability Source Type: news

Autologous HSCT Improves Long-Term Survival Autologous HSCT Improves Long-Term Survival
Patients with rapidly progressive systemic sclerosis could find long-term mortality benefits from autologous hematopoietic stem cell transplantation.Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

CV Risk Score Multipliers Suggested for Rheumatic Diseases CV Risk Score Multipliers Suggested for Rheumatic Diseases
Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other rheumatic disease.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 30, 2022 Category: Cardiology Tags: Rheumatology News Source Type: news